MCIM
MYOK

Meadow Creek Investment Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Meadow Creek Investment Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$46K Hold
884
– – ﹤0.01% 1271
2019
Q2 		$44K Hold
884
– – ﹤0.01% 1289
2019
Q1 		$46K Buy
884
+204
+30% +$9.4K ﹤0.01% 1271
2018
Q4 		$33K Buy
+680
New +$37.4K ﹤0.01% 1238

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Meadow Creek Investment Management's MYOK Position: Q3 2019 in Review

Meadow Creek Investment Management held its MyoKardia, Inc. Common Stock (MYOK) position steady in Q3 2019 at 884 shares worth $46K. The position accounts for ﹤0.01% of the portfolio, ranked #1271.

Meadow Creek Investment Management first reported a position in MYOK in Q4 2018 and has held it in 4 quarters since. 157 funds tracked by Wall St. Rank hold MYOK as of Q3 2019.

  • Meadow Creek Investment Management held 884 shares of MyoKardia, Inc. Common Stock worth $46K as of Q3 2019.
  • Meadow Creek Investment Management left its MyoKardia, Inc. Common Stock share count unchanged in Q3 2019.
  • MyoKardia, Inc. Common Stock made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1271 holding.
  • Meadow Creek Investment Management first reported a position in MyoKardia, Inc. Common Stock in Q4 2018 and has held it in 4 quarters since.
  • 157 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.